Danaher Corporation (NYSE: DHR) (“Danaher”), a Washington, DC-based life sciences and diagnostics innovator, acquired Genedata AG, a Basel Switzerland-based supplier of software program options for biopharmaceutical R&D.
The quantity of the deal was not disclosed.
With the acquisition, Danaher Company will increase its choices.
Genedata delivers scalable and open options that improve R&D productiveness, serving biopharmaceutical corporations and progressive biotechnology organizations.
Danaher is a life sciences and diagnostics innovator. Its companies associate intently with clients to assist clear up a lot of a very powerful well being challenges impacting sufferers world wide. Its superior science and expertise assist allow sooner, extra correct diagnoses and assist cut back the time and value wanted to sustainably uncover, develop and ship life-changing therapies.
FinSMEs
20/08/2024
